Works matching IS 26882663 AND DT 2022 AND VI 3 AND IP 2

Results: 20

Role of chemokine systems in cancer and inflammatory diseases.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.147
By:
- Li, Hongyi;
- Wu, Min;
- Zhao, Xia
Publication type:
Article
Pathogenesis and treatment of multiple myeloma.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.146
By:
- Yang, Peipei;
- Qu, Ying;
- Wang, Mengyao;
- Chu, Bingyang;
- Chen, Wen;
- Zheng, Yuhuan;
- Niu, Ting;
- Qian, Zhiyong
Publication type:
Article
Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.144
By:
- Huang, Zhao;
- Zhang, Zhe;
- Zhou, Chengwei;
- Liu, Lin;
- Huang, Canhua
Publication type:
Article
Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.143
By:
- Zhou, Zhongcheng;
- Du, Peng;
- Li, Ning;
- Xiong, Xinxin;
- Tang, Shengjun;
- Dai, Qinjin;
- Wang, Taorui;
- Yu, Meixing;
- Man, Miao;
- Lam, Kelvin;
- Baptista‐Hon, Daniel T.;
- Tai, Wa Hou;
- Monteiro, Olivia;
- Ng, Weng Sam;
- Lee, Un Man;
- Liu, Zhihai;
- Zhang, Kang;
- Li, Gen
Publication type:
Article
Erratum.
Published in:
2022
Publication type:
Correction Notice
LncRNAs and CircRNAs in cancer.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.141
By:
- Yin, Xin;
- Lin, Huiran;
- Lin, Lei;
- Miao, Lei;
- He, Jing;
- Zhuo, Zhenjian
Publication type:
Article
Programmed death‐ligand 1 expression on CD22‐specific chimeric antigen receptor‐modified T cells weakens antitumor potential.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.140
By:
- Liu, Jie;
- Zhang, Fengjuan;
- Yu, Jian;
- Zhao, Qi
Publication type:
Article
TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration.
Published in:
2022
By:
- Gao, Rui;
- Meng, Mei;
- Zhou, Xianchao;
- Yu, Miao;
- Li, Zhifan;
- Li, Jingquan;
- Wang, Xiaonan;
- Song, Yizhi;
- Wang, Hui;
- He, Jian
Publication type:
Letter to the Editor
A next‐generation vaccine for broader and long‐lasting COVID‐19 protection.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.138
By:
- Xi, Jinxiang;
- Si, Xiuhua April
Publication type:
Article
Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.137
By:
- Jiang, Zhongyi;
- Zhu, Haitao;
- Wang, Pusen;
- Que, Weitao;
- Zhong, Lin;
- Li, Xiao‐Kang;
- Du, Futian
Publication type:
Article
Erratum.
Published in:
2022
Publication type:
Correction Notice
Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.132
By:
- Dai, Ji‐Min;
- Zhang, Xue‐Qin;
- Zhang, Jia‐Jia;
- Yang, Wei‐Jie;
- Yang, Xiang‐Min;
- Bian, Huijie;
- Chen, Zhi‐Nan
Publication type:
Article
Deletion of Trp53 and Rb1 in Ctsk‐expressing cells drives osteosarcoma progression by activating glucose metabolism and YAP signaling.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.131
By:
- Li, Yang;
- Yang, Shuting;
- Liu, Yang;
- Yang, Shuying
Publication type:
Article
Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.130
By:
- Li, Qianqian;
- Zhang, Mengyi;
- Liang, Ziteng;
- Zhang, Li;
- Wu, Xi;
- Yang, Chaoying;
- An, Yimeng;
- Tong, Jincheng;
- Liu, Shuo;
- Li, Tao;
- Cui, Qianqian;
- Nie, Jianhui;
- Wu, Jiajing;
- Huang, Weijin;
- Wang, Youchun
Publication type:
Article
Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.129
By:
- Yang, Hao;
- Liu, Penghui;
- Zhang, Yong;
- Du, Tingfu;
- Zhou, Yanan;
- Lu, Shuaiyao;
- Peng, Xiaozhong
Publication type:
Article
Redox signaling at the crossroads of human health and disease.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.127
By:
- Zuo, Jing;
- Zhang, Zhe;
- Luo, Maochao;
- Zhou, Li;
- Nice, Edouard C.;
- Zhang, Wei;
- Wang, Chuang;
- Huang, Canhua
Publication type:
Article
Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.125
By:
- Li, Jiao;
- Zhou, Jian‐Kang;
- Mu, Xiaoyu;
- Shen, Shu;
- Xu, Xiaomin;
- Luo, Yao;
- Luo, Yuxin;
- Ming, Yue;
- Wu, Yuangang;
- Peng, Yong
Publication type:
Article
STAT3 pathway in cancers: Past, present, and future.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.124
By:
- Wang, Han‐Qi;
- Man, Qi‐Wen;
- Huo, Fang‐Yi;
- Gao, Xin;
- Lin, Hao;
- Li, Su‐Ran;
- Wang, Jing;
- Su, Fu‐Chuan;
- Cai, Lulu;
- Shi, Yi;
- Liu, Bing;
- Bu, Lin‐Lin
Publication type:
Article
SENP3‐mediated TIP60 deSUMOylation is required for DNA‐PKcs activity and DNA damage repair.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.123
By:
- Han, Yang;
- Huang, Xin;
- Cao, Xiaoyu;
- Li, Yuchen;
- Gao, Lei;
- Jia, Jin;
- Li, Gang;
- Guo, Hejiang;
- Liu, Xiaochang;
- Zhao, Hongling;
- Guan, Hua;
- Zhou, Pingkun;
- Gao, Shanshan
Publication type:
Article
Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice.
Published in:
MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.117
By:
- Fang, Enyue;
- Liu, Xinyu;
- Liu, Xiaohui;
- Li, Ming;
- Wang, Ling;
- Li, Miao;
- Zhang, Zelun;
- Li, Yuhua;
- Yu, Yongxin
Publication type:
Article